down arrow

Medicure, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA58469E4085
  • TSX: MPH
CAD
2.74
0.05 (1.86%)

Sep 22

TSX

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Medicure, Inc.
Valeo Pharma, Inc.
Devonian Health Group, Inc.
Helix BioPharma Corp.
Resverlogix Corp.
Avricore Health, Inc.
Aptose Biosciences, Inc.
Alpha Cognition, Inc.
Satellos Bioscience, Inc.
Antibe Therapeutics, Inc.
Sirona Biochem Corp.

Why is Medicure, Inc. ?

1
Poor Management Efficiency with a low ROE of 0.78%
  • The company has been able to generate a Return on Equity (avg) of 0.78% signifying low profitability per unit of shareholders funds
2
Flat results in Mar 26
  • INTEREST(9M) At CAD 0.02 MM has Grown at inf%
  • NET PROFIT(HY) At CAD -4.63 MM has Grown at -271.05%
  • OPERATING CASH FLOW(Y) Lowest at CAD -3.04 MM
3
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -3.60%, its profits have fallen by -87.1%
4
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -3.60% returns in the last 1 year, the stock has also underperformed S&P/TSX 60 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Medicure, Inc. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Medicure, Inc.
149.09%
-0.58
102.26%
S&P/TSX 60
20.36%
2.23
12.57%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
18.26%
EBIT Growth (5y)
0.50%
EBIT to Interest (avg)
-2.16
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.34
Sales to Capital Employed (avg)
1.36
Tax Ratio
2.70%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.01%
ROCE (avg)
1.01%
ROE (avg)
0.78%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.05
EV to EBIT
-1.86
EV to EBITDA
-3.10
EV to Capital Employed
1.06
EV to Sales
0.39
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-56.99%
ROE (Latest)
-53.75%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

4What is working for the Company
NET PROFIT(HY)

Higher at CAD -1.83 MM

DEBTORS TURNOVER RATIO(HY)

Highest at 6.54 times

-15What is not working for the Company
NET PROFIT(9M)

At CAD -6.05 MM has Grown at -197.84%

INTEREST(9M)

At CAD 0.03 MM has Grown at inf%

OPERATING CASH FLOW(Y)

Lowest at CAD -1.92 MM

ROCE(HY)

Lowest at -49.88%

RAW MATERIAL COST(Y)

Grown by 16.73% (YoY

CASH AND EQV(HY)

Lowest at CAD 3.37 MM

DEBT-EQUITY RATIO (HY)

Highest at -9.82 %

Here's what is working for Medicure, Inc.

Net Profit
Higher at CAD -1.83 MM
than preceding 12 month period ended Jun 2026
MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (CAD MM)

Debtors Turnover Ratio
Highest at 6.54 times and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Here's what is not working for Medicure, Inc.

Interest
At CAD 0.03 MM has Grown at inf%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CAD MM)

Operating Cash Flow
Lowest at CAD -1.92 MM
in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (CAD MM)

Cash and Eqv
Lowest at CAD 3.37 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debt-Equity Ratio
Highest at -9.82 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Raw Material Cost
Grown by 16.73% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Footer loading